Nasal Cannula Market is estimated to be valued at USD 8.71 Bn in 2025 and is expected to reach USD 13.45 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.
The world nasal cannula market is witnessing steady growth due to the growing incidence of respiratory conditions such as COPD and the aging population. Improved nasal cannula technology, providing improved comfort and efficiency, is enhancing market demand. Nevertheless, obstacles such as increased healthcare expenditure and restricted access in rural areas might slow growth. In spite of this, emerging economies such as India and China offer great opportunities based on increasing healthcare demands. Chinese firms are making great leaps in high-flow nasal cannula technology. Developments include better oxygen concentration adjustment, enhanced humidification efficiency, and greater patient comfort. There is also a trend towards incorporating smart features like automatic alarms and smart regulation, with the aim of offering more efficient and personalized respiratory therapy.
|
Current Events |
Description and its impact |
|
Advancements in Nasal Cannula Technology |
|
|
Integration with Smart Technologies
|
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
On the basis of product type, the market is divided into curved prong cannula, flared prong cannula, straight prong cannula, and curved and flared prong cannula. Among which, curved prong cannula is anticipated to maintain a commanding position in the global nasal cannula market over the forecast period, and this is due to rising organic growth initiatives like product launches and approvals.
By application, the market is divided into asthma, lung cancer, chronic bronchitis, pulmonary embolism, COPD, cystic fibrosis, pneumonia, and others. Among which, COPD is anticipated to hold the largest share in the market during the forecast period, and this is due to the rising utilization of nasal cannulas for COPD treatment.
Based on material, the market is divided into plastic and sillion. Among them, sillion will lead the market during the forecast period, and this is due to the growing application of sillion material for the production of nasal cannula.
On the basis of end user, the market has been divided into hospital, long term care center, home care settings, ambulatory surgical centers, and others. Among all these, the hospital is going to hold larger market share during the forecasting period. This is because the hospitals are making larger usage of the nasal cannula.
To learn more about this report, Download Free Sample
Amongst the various regions, the North American market is projected to be in command of the nasal cannula industry worldwide during the forecast period. North America is projected to control 33.5% of the market in 2025. The nasal cannula market will observe considerable growth in the near future, driven by rising organic growth initiatives like the launch of products by leading players in order to enhance their product offerings in the North American region.
For example, in October 2021, Movair, a respiratory therapy company that used to be known as International Biophysics Corporation, revealed the U.S. commercial launch of Luisa, an innovative ventilator for home use, institutions, hospitals, or portable applications for invasive and non-invasive ventilation. Luisa also offers the added benefit of toggling between a high-flow nasal cannula (HFNC) and a non-invasive ventilator (NIV) with variable modes at the touch of a button.
The United States leads the worldwide nasal cannula market, with its well-established healthcare infrastructure, high incidence of respiratory conditions such as COPD, and widespread adoption of medical technologies. Major healthcare and medical device companies have their bases in the country, leading to developments in nasal cannula products. Favourable reimbursement policies and higher healthcare expenditure further fuel the growth of the market.
China is also experiencing high growth in the market for nasal cannulas because it has a vast population, an escalating incidence of respiratory diseases, and a mounting healthcare burden. China is investing heavily in building up its healthcare infrastructure, leading to a rise in demand for respiratory support equipment and medical oxygen. China's market is also favourably affected by technological advances such as the use of high-flow nasal cannulas, which are more patient-friendly and offer more efficient treatment.
India is a fast-growing market for nasal cannulas, fuelled by its huge population and the growing incidence of respiratory diseases like asthma and COPD. The market for respiratory care devices is expanding as access to healthcare improves, particularly in urban regions. Advances in nasal cannula technology, including low-cost, high-efficiency designs, are also driving market growth. India's growing healthcare industry and increasing healthcare demand make it a major player in the global market.
Germany dominates the European market for nasal cannula, having a highly developed health care system and a strong need for respiratory devices caused by the population's aging process and the prevalence of respiratory diseases. Germany enjoys the support of its domestic production potential and ongoing innovations in the field of nasal cannula technology that helps to consolidate its market share in Europe.
Nasal Cannula Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.71 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.4% | 2032 Value Projection: | USD 13.45 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Medtronic, Devex,Edwards Lifesciences Corporation, Terumo Corporation, LivaNova PLC, medin Medical Innovations GmbH, Flexicare (Group) Limited, Medline Industries, LP, Teleflex Incorporated, Vapotherm, Salter Labs, Well Lead Medical Co., Ltd., Drive Devilbiss International, Allied Medical Limited, Besmed Health Business Corp., Fairmont Medical, Smiths Medical, Fisher & Paykel Healthcare Limited., ResMed |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Definition: A nasal cannula is a device that gives additional oxygen (supplemental oxygen or oxygen therapy) through nose. It’s a thin, flexible tube that goes around head and into nose. There are two prongs that go inside nostrils that deliver the oxygen. The tube is attached to an oxygen source like a tank or container. There are high-flow nasal cannulas (HFNC) and low-flow nasal cannulas (LFNC). The difference between them is in the amount and type of oxygen they deliver per minute.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
